Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin.

Slupianek A, Gurdek E, Koptyra M, Nowicki MO, Siddiqui KM, Groden J, Skorski T. BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin. Oncogene. 2005 Jun 02; 24(24):3914-22.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.